The University of Oxford is part of a £15.9 million UK-wide programme to develop human tumour tissue models, improving cancer research, accelerating drug discovery and reducing reliance on animal testing.
Professor Carmen Lamacchia is the inventor of a new gluten friendly technology that promises to make bread and pasta safe for people with coeliac disease
As antibiotics become less effective against infection, Minister of Health, Jane Philpott, outlines the response to antimicrobial resistance in Canada.
University of Illinois’ Dr. Benjamin Van Voorhees explains how the CATCH-IT intervention is fighting against depression using a behavioural vaccine approach
Jean-Michel Letennier, President and CEO of Atomic Information Systems (AIS) Corporation, outlines how their software solutions can change how organisations think
AIS Corporation is a full...
By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here
Innovation is the lifeblood...
UEHP President Dr Paul Garassus writes on the importance of investing in smart private hospitals for sustainable healthcare
In an historical moment in which uncertainty...